Effectiveness of confidential unit exclusion in screening blood donors of the regional blood bank in Londrina, Paraná State
Autor(a) principal: | |
---|---|
Data de Publicação: | 2011 |
Outros Autores: | , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Revista brasileira de hematologia e hemoterapia (Online) |
Texto Completo: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1516-84842011000500010 |
Resumo: | BACKGROUND: For transfusion purposes, blood donors must be accepted both in clinical and serological evaluations and must not have excluded their own donation using the confidential unit exclusion. AIMS: The objective of this study was to verify whether blood donors who choose self exclusion are more likely to be positive in serological tests than donors who do not. METHODS: A cross-sectional analysis was carried out of 51,861 consecutive whole blood donations from January 2004 to December 2008 at a public blood bank in Londrina, Southern Brazil. RESULTS: Self exclusion was chosen in 1672 (3.2%) donations, most frequently by first-time blood donors (p-value < 0.0001), by blood donors from external collections (p-value < 0.0001), by men (p value < 0.0001) and by under 30-year-old donors (p-value < 0.0001). The frequency of positive serology was 5.3% in the group that chose self exclusion and 3.5% in the group that did not choose self exclusion (p-value < 0.0001). CONCLUSIONS: These results show that confidential unit exclusion used in this blood bank is effective and is inexpensive. However, the diagnostic power to detect blood-borne infections was low and resulted in the discard of a high number of blood bags without any direct or indirect serologic markers of pathogens. The use of confidential unit exclusion could be replaced with molecular tests to screen blood donors. |
id |
ABHHTC-1_9fd8bc810b37a451ea4cd54f73c4365e |
---|---|
oai_identifier_str |
oai:scielo:S1516-84842011000500010 |
network_acronym_str |
ABHHTC-1 |
network_name_str |
Revista brasileira de hematologia e hemoterapia (Online) |
repository_id_str |
|
spelling |
Effectiveness of confidential unit exclusion in screening blood donors of the regional blood bank in Londrina, Paraná StateDonor selectionSerologic testsDiagnosisBlood transfusionBACKGROUND: For transfusion purposes, blood donors must be accepted both in clinical and serological evaluations and must not have excluded their own donation using the confidential unit exclusion. AIMS: The objective of this study was to verify whether blood donors who choose self exclusion are more likely to be positive in serological tests than donors who do not. METHODS: A cross-sectional analysis was carried out of 51,861 consecutive whole blood donations from January 2004 to December 2008 at a public blood bank in Londrina, Southern Brazil. RESULTS: Self exclusion was chosen in 1672 (3.2%) donations, most frequently by first-time blood donors (p-value < 0.0001), by blood donors from external collections (p-value < 0.0001), by men (p value < 0.0001) and by under 30-year-old donors (p-value < 0.0001). The frequency of positive serology was 5.3% in the group that chose self exclusion and 3.5% in the group that did not choose self exclusion (p-value < 0.0001). CONCLUSIONS: These results show that confidential unit exclusion used in this blood bank is effective and is inexpensive. However, the diagnostic power to detect blood-borne infections was low and resulted in the discard of a high number of blood bags without any direct or indirect serologic markers of pathogens. The use of confidential unit exclusion could be replaced with molecular tests to screen blood donors.Associação Brasileira de Hematologia e Hemoterapia e Terapia Celular2011-10-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1516-84842011000500010Revista Brasileira de Hematologia e Hemoterapia v.33 n.5 2011reponame:Revista brasileira de hematologia e hemoterapia (Online)instname:Associação Brasileira de Hematologia e Hemoterapia e Terapia Celular (ABHHTC)instacron:ABHHTC10.5581/1516-8484.20110097info:eu-repo/semantics/openAccessVogler,Ingridt HildegardSaito,MarizaSpinosa,Adriana AparecidaSilva,Marilza Celina daMunhoz,EgbertoReiche,Edna Maria Vissocieng2011-11-22T00:00:00Zoai:scielo:S1516-84842011000500010Revistahttp://www.rbhh.org/pt/archivo/https://old.scielo.br/oai/scielo-oai.phpsbhh@terra.com.br||secretaria@rbhh.org1806-08701516-8484opendoar:2011-11-22T00:00Revista brasileira de hematologia e hemoterapia (Online) - Associação Brasileira de Hematologia e Hemoterapia e Terapia Celular (ABHHTC)false |
dc.title.none.fl_str_mv |
Effectiveness of confidential unit exclusion in screening blood donors of the regional blood bank in Londrina, Paraná State |
title |
Effectiveness of confidential unit exclusion in screening blood donors of the regional blood bank in Londrina, Paraná State |
spellingShingle |
Effectiveness of confidential unit exclusion in screening blood donors of the regional blood bank in Londrina, Paraná State Vogler,Ingridt Hildegard Donor selection Serologic tests Diagnosis Blood transfusion |
title_short |
Effectiveness of confidential unit exclusion in screening blood donors of the regional blood bank in Londrina, Paraná State |
title_full |
Effectiveness of confidential unit exclusion in screening blood donors of the regional blood bank in Londrina, Paraná State |
title_fullStr |
Effectiveness of confidential unit exclusion in screening blood donors of the regional blood bank in Londrina, Paraná State |
title_full_unstemmed |
Effectiveness of confidential unit exclusion in screening blood donors of the regional blood bank in Londrina, Paraná State |
title_sort |
Effectiveness of confidential unit exclusion in screening blood donors of the regional blood bank in Londrina, Paraná State |
author |
Vogler,Ingridt Hildegard |
author_facet |
Vogler,Ingridt Hildegard Saito,Mariza Spinosa,Adriana Aparecida Silva,Marilza Celina da Munhoz,Egberto Reiche,Edna Maria Vissoci |
author_role |
author |
author2 |
Saito,Mariza Spinosa,Adriana Aparecida Silva,Marilza Celina da Munhoz,Egberto Reiche,Edna Maria Vissoci |
author2_role |
author author author author author |
dc.contributor.author.fl_str_mv |
Vogler,Ingridt Hildegard Saito,Mariza Spinosa,Adriana Aparecida Silva,Marilza Celina da Munhoz,Egberto Reiche,Edna Maria Vissoci |
dc.subject.por.fl_str_mv |
Donor selection Serologic tests Diagnosis Blood transfusion |
topic |
Donor selection Serologic tests Diagnosis Blood transfusion |
description |
BACKGROUND: For transfusion purposes, blood donors must be accepted both in clinical and serological evaluations and must not have excluded their own donation using the confidential unit exclusion. AIMS: The objective of this study was to verify whether blood donors who choose self exclusion are more likely to be positive in serological tests than donors who do not. METHODS: A cross-sectional analysis was carried out of 51,861 consecutive whole blood donations from January 2004 to December 2008 at a public blood bank in Londrina, Southern Brazil. RESULTS: Self exclusion was chosen in 1672 (3.2%) donations, most frequently by first-time blood donors (p-value < 0.0001), by blood donors from external collections (p-value < 0.0001), by men (p value < 0.0001) and by under 30-year-old donors (p-value < 0.0001). The frequency of positive serology was 5.3% in the group that chose self exclusion and 3.5% in the group that did not choose self exclusion (p-value < 0.0001). CONCLUSIONS: These results show that confidential unit exclusion used in this blood bank is effective and is inexpensive. However, the diagnostic power to detect blood-borne infections was low and resulted in the discard of a high number of blood bags without any direct or indirect serologic markers of pathogens. The use of confidential unit exclusion could be replaced with molecular tests to screen blood donors. |
publishDate |
2011 |
dc.date.none.fl_str_mv |
2011-10-01 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1516-84842011000500010 |
url |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1516-84842011000500010 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
10.5581/1516-8484.20110097 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
text/html |
dc.publisher.none.fl_str_mv |
Associação Brasileira de Hematologia e Hemoterapia e Terapia Celular |
publisher.none.fl_str_mv |
Associação Brasileira de Hematologia e Hemoterapia e Terapia Celular |
dc.source.none.fl_str_mv |
Revista Brasileira de Hematologia e Hemoterapia v.33 n.5 2011 reponame:Revista brasileira de hematologia e hemoterapia (Online) instname:Associação Brasileira de Hematologia e Hemoterapia e Terapia Celular (ABHHTC) instacron:ABHHTC |
instname_str |
Associação Brasileira de Hematologia e Hemoterapia e Terapia Celular (ABHHTC) |
instacron_str |
ABHHTC |
institution |
ABHHTC |
reponame_str |
Revista brasileira de hematologia e hemoterapia (Online) |
collection |
Revista brasileira de hematologia e hemoterapia (Online) |
repository.name.fl_str_mv |
Revista brasileira de hematologia e hemoterapia (Online) - Associação Brasileira de Hematologia e Hemoterapia e Terapia Celular (ABHHTC) |
repository.mail.fl_str_mv |
sbhh@terra.com.br||secretaria@rbhh.org |
_version_ |
1754213111503519744 |